China’s Shanxi Jintaoyuan to build new cyclohexanone, capro units

18 February 2013 04:52  [Source: ICIS news]

SINGAPORE (ICIS)--China’s Shanxi Jintaoyuan (Group) Co Ltd plans to invest yuan (CNY) 2.2bn ($353m) to build a cylohexanone unit and a caprolactam plant in Shanxi province, a source close to the company said on Monday.

The proposed cyclohexanone unit will have a 200,000 tonne/year capacity, while the coal-based capro unit will have the same capacity, the source said.

Timeline for construction has yet to be set, the source said, adding that environmental assessment for the project is ongoing.

Shanxi Jintaoyuan is a diversified company engaged in raw coal exploration, coke production, magnesium metal smelting and trading.

($1 = CNY6.23)


By: Viola Pan
+65 6780 4359



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly